Fulgent Genetics Insider Report: Hsieh Retains Large Stake After RSU Withholding
Rhea-AI Filing Summary
Ming Hsieh, Fulgent Genetics (FLGT) director, CEO and 10% owner, reported a withholding of 2,115 common shares on 08/23/2025 at a price of $21.77 per share to satisfy tax withholding upon vesting of restricted stock units granted on 02/23/2023. After the withholding, Mr. Hsieh directly holds 807,225 shares and retains substantial indirect holdings: 7,895,115 shares held by a Dynasty Trust, 220,816 shares held by the Ming Hsieh Trust, and two 1,000-share UTMA accounts for which he is custodian. The Form 4 was signed by an attorney-in-fact on 08/26/2025. The filing clarifies the trust relationships and voting/dispositive powers for the indirect holdings.
Positive
- Transaction was a tax-withholding on RSU vesting, not an open-market sale, reducing signals of insider cashing out
- Substantial insider ownership retained: 807,225 shares direct plus 7,895,115 and 220,816 shares indirectly, indicating continued alignment with shareholders
- Trust relationships and voting/dispositive powers are clearly disclosed, supporting governance transparency
Negative
- None.
Insights
TL;DR: A small tax-withholding disposition occurred; Hsieh retains large direct and indirect ownership, so control and alignment with shareholders remain intact.
The 2,115-share disposition is identified as a tax-withholding event tied to RSU vesting, not an open-market sale, limiting its informational significance for valuation models. The reported direct stake of 807,225 shares plus material indirect holdings (7,895,115 and 220,816 shares) indicate substantial insider ownership that could affect float and voting dynamics. No derivatives or other sales are disclosed. Impact on liquidity or immediate share supply is minimal given the small size of the withheld shares relative to reported beneficial holdings.
TL;DR: Disclosure is routine and transparent; trust structures and voting power are clearly stated, supporting governance transparency.
The filing provides explicit descriptions of the Dynasty Trust and the Hsieh Trust, including Mr. Hsieh's roles (grantor, trustee) and disclaimers of beneficial interest where applicable. The transaction was processed via tax withholding upon RSU vesting and documented with an attorney-in-fact signature, which aligns with standard insider reporting practices. There are no indications of unusual related-party transfers or changes in control from this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 2,115 | $21.77 | $46K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
